The stock of Vicarious Surgical Inc (NYSE: RBOT) has increased by 14.53 when compared to last closing price of 11.49.Despite this, the company has seen a gain of 41.20% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief Executive Officer Bill Kelly – Chief Financial Officer Conference Call Participants Adam Maeder – Piper Sandler Operator Hello, everyone, and welcome to Vicarious Surgical’s Third Quarter 2024 Earnings Call. My name is Lydia and I’ll be your operator today.
Is It Worth Investing in Vicarious Surgical Inc (NYSE: RBOT) Right Now?
The 36-month beta value for RBOT is also noteworthy at 1.17. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for RBOT is 2.66M, and at present, short sellers hold a 2.48% of that float. The average trading volume of RBOT on November 26, 2024 was 19.24K shares.
RBOT’s Market Performance
RBOT’s stock has seen a 41.20% increase for the week, with a 65.73% rise in the past month and a 87.46% gain in the past quarter. The volatility ratio for the week is 12.78%, and the volatility levels for the past 30 days are at 12.07% for Vicarious Surgical Inc The simple moving average for the past 20 days is 41.42% for RBOT’s stock, with a 57.25% simple moving average for the past 200 days.
Analysts’ Opinion of RBOT
Many brokerage firms have already submitted their reports for RBOT stocks, with Piper Sandler repeating the rating for RBOT by listing it as a “Neutral.” The predicted price for RBOT in the upcoming period, according to Piper Sandler is $7 based on the research report published on March 04, 2022 of the previous year 2022.
Credit Suisse, on the other hand, stated in their research note that they expect to see RBOT reach a price target of $16. The rating they have provided for RBOT stocks is “Outperform” according to the report published on January 07th, 2022.
Cowen gave a rating of “Outperform” to RBOT, setting the target price at $15 in the report published on December 07th of the previous year.
RBOT Trading at 71.39% from the 50-Day Moving Average
After a stumble in the market that brought RBOT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.58% of loss for the given period.
Volatility was left at 12.07%, however, over the last 30 days, the volatility rate increased by 12.78%, as shares surge +57.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +129.27% upper at present.
During the last 5 trading sessions, RBOT rose by +41.20%, which changed the moving average for the period of 200-days by +6.99% in comparison to the 20-day moving average, which settled at $9.31. In addition, Vicarious Surgical Inc saw 19.63% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RBOT starting from Sachs Adam David, who sale 817 shares at the price of $8.97 back on Nov 20 ’24. After this action, Sachs Adam David now owns 54,244 shares of Vicarious Surgical Inc, valued at $7,328 using the latest closing price.
Khalifa Sammy, the Chief Technology Officer of Vicarious Surgical Inc, sale 653 shares at $8.97 during a trade that took place back on Nov 20 ’24, which means that Khalifa Sammy is holding 38,032 shares at $5,856 based on the most recent closing price.
Stock Fundamentals for RBOT
Current profitability levels for the company are sitting at:
- -19.45 for the present operating margin
- 0.54 for the gross margin
The net margin for Vicarious Surgical Inc stands at -18.09. The total capital return value is set at -0.93. Equity return is now at value -75.30, with -58.69 for asset returns.
Based on Vicarious Surgical Inc (RBOT), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -42.27. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -3050.82.
Currently, EBITDA for the company is -69.19 million with net debt to EBITDA at -0.12. When we switch over and look at the enterprise to sales, we see a ratio of 24.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.44.
Conclusion
In summary, Vicarious Surgical Inc (RBOT) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
